Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

164,845 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reducing Target Volumes of Intensity Modulated Radiation Therapy After Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: Long-Term Results of a Prospective, Multicenter, Randomized Trial.
Xiang L, Rong JF, Xin-Chen, Li XY, Zheng Y, Ren PR, Lin S, Wen QL, He LJ, Zhang JW, Shang CL, Yang HR, Fan J, Pang HW, Zhang J, Tan BX, Zhang L, Du XB, Wen SM, Jiang L, Qin G, Wu JB. Xiang L, et al. Among authors: zhang l, zhang jw, zhang j. Int J Radiat Oncol Biol Phys. 2023 Nov 15;117(4):914-924. doi: 10.1016/j.ijrobp.2023.06.001. Epub 2023 Jun 24. Int J Radiat Oncol Biol Phys. 2023. PMID: 37356553 Clinical Trial.
Computed Tomography-Guided Interstitial High-Dose-Rate Brachytherapy in Combination With Regional Positive Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: A Phase 1 Clinical Trial.
Xiang L, Zhang JW, Lin S, Luo HQ, Wen QL, He LJ, Shang CL, Ren PR, Yang HR, Pang HW, Yang B, He HL, Chen Y, Wu JB. Xiang L, et al. Int J Radiat Oncol Biol Phys. 2015 Aug 1;92(5):1027-1034. doi: 10.1016/j.ijrobp.2015.04.019. Epub 2015 Apr 17. Int J Radiat Oncol Biol Phys. 2015. PMID: 26194678 Clinical Trial.
Treatment outcomes after reduction of the target volume of intensity-modulated radiotherapy following induction chemotherapy in patients with locoregionally advanced nasopharyngeal carcinoma: A prospective, multi-center, randomized clinical trial.
Yang H, Chen X, Lin S, Rong J, Yang M, Wen Q, Shang C, He L, Ren P, Xu S, Zhang J, Liu Q, Pang H, Shi X, Fan J, Sun X, Ma D, Tan B, Zhang T, Zhang L, Hu D, Du X, Zhang Y, Wen S, Zhang X, Wu J. Yang H, et al. Among authors: zhang l, zhang t, zhang j, zhang x, zhang y. Radiother Oncol. 2018 Jan;126(1):37-42. doi: 10.1016/j.radonc.2017.07.020. Epub 2017 Aug 29. Radiother Oncol. 2018. PMID: 28864073 Clinical Trial.
Effect of 3-Dimensional Interstitial High-Dose-Rate Brachytherapy With Regional Metastatic Lymph Node Intensity-Modulated Radiation Therapy in Locally Advanced Peripheral Non-Small Cell Lung Cancer: 5-Year Follow-up of a Phase 2 Clinical Trial.
Xiang L, Ren PR, Li HX, Ye H, Pang HW, Wen QL, Zhang JW, He LH, Shang CL, Yang BY, Lin SL, Wu JW. Xiang L, et al. Int J Radiat Oncol Biol Phys. 2023 Feb 1;115(2):347-355. doi: 10.1016/j.ijrobp.2022.07.028. Epub 2022 Jul 25. Int J Radiat Oncol Biol Phys. 2023. PMID: 35901979 Clinical Trial.
PD-L1 expression on circulating tumor cells can be a predictive biomarker to PD-1 inhibitors combined with radiotherapy and antiangiogenic therapy in advanced hepatocellular carcinoma.
Su K, Guo L, He K, Rao M, Zhang J, Yang X, Huang W, Gu T, Xu K, Liu Y, Wang J, Chen J, Wu Z, Hu L, Zeng H, Li H, Tong J, Li X, Yang Y, Liu H, Xu Y, Tan Z, Tang X, Feng X, Chen S, Yang B, Jin H, Zhu L, Li B, Han Y. Su K, et al. Among authors: zhang j. Front Oncol. 2022 Aug 2;12:873830. doi: 10.3389/fonc.2022.873830. eCollection 2022. Front Oncol. 2022. PMID: 35982979 Free PMC article.
164,845 results
You have reached the last available page of results. Please see the User Guide for more information.